Abbott Laboratories Most people probably know healthcare giant Abbott Laboratories (NYSE: ABT) best for its COVID-19 rapid test, BinaxNOW. Persistently high inflation, huge interest-rate hikes, and military conflict in Ukraine have significantly raised the probability of a global recession. And the company has a pipeline of 87 projects in different stages of clinical development across multiple therapy areas, such as immunology, oncology, and vaccines.